ADC Therapeutics News

ADC Therapeutics | 8-K: Current report

Nov 13 16:18 ET

ADC Therapeutics | DEFA14A: Others

Sep 23 16:44 ET

ADC Therapeutics | DEF 14A: Definitive information statements

Sep 23 16:39 ET

ADC Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Sep 13 16:21 ET

ADC Therapeutics | S-3: Registration statement for specified transactions by certain issuers

Aug 6 16:30 ET

ADC Therapeutics | 8-K: Current report

Jun 14 16:15 ET

ADC Therapeutics | 8-K: Current report

May 14 12:34 ET

ADC Therapeutics | 8-K: Current report

May 8 17:27 ET

ADC Therapeutics | DEF 14A: Definitive information statements

Apr 26 16:34 ET

ADC Therapeutics | DEFA14A: Others

Apr 26 16:26 ET

ADC Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 16 16:22 ET

ADC Therapeutics | 8-K: Current report

Apr 9 16:12 ET

ADC Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 13 16:23 ET

ADC Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 13 16:21 ET

ADC Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Mar 13 16:20 ET

ADC Therapeutics | 8-K: Current report

Mar 5 09:17 ET

ADC Therapeutics | 8-K: Current report

Feb 29 16:34 ET

ADC Therapeutics | 8-K: Current report

Jan 24 08:04 ET

ADC Therapeutics | 8-K: Current report

Jan 19 00:00 ET

ADC Therapeutics | 8-K: Current report

Jan 4 00:00 ET